Literature DB >> 12415468

Residential water supply as a likely cause of community-acquired Legionnaires' disease in an immunocompromised host.

Y-S Chen1, W-R Lin, Y-C Liu, C-L Chang, V-L Gan, W-K Huang, T-S Huang, S-R Wann, H-H Lin, S S-J Lee, C-K Huang, C Chin, Y-S E Lin, M-Y Yen.   

Abstract

A 69-year-old man with Sweet's syndrome and myelodysplastic syndrome presented with pneumonia and respiratory distress. He had been taking corticosteroids and methotrexate. The diagnosis of Legionnaires' disease was established by the isolation of Legionella pneumophila serogroup 6 from sputum and a fourfold seroconversion of Legionella antibodies to 1:512. Legionella pneumophila serogroup 6 was isolated from faucets in two homes owned by the patient. Strains of Legionella pneumophila serogroup 6 isolated from the patient's sputum and from one home were demonstrated to be genetically identical by pulsed-field gel electrophoresis but different from strains found in the other home and in a hospital outpatient clinic that he visited. This case illustrates an emerging public health issue concerning acquisition of community-acquired Legionnaires' disease from the homes of immunocompromised hosts. This is the first such case reported in Asia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415468     DOI: 10.1007/s10096-002-0815-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

1.  Rapid identification of Legionella pneumophila serogroups by latex agglutination.

Authors:  M Reyrolle; C Ratat; M Leportier; S Jarraud; J Freney; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-09       Impact factor: 3.267

2.  Is domestic tap water a risk for infections in neutropenic patients?

Authors:  H von Baum; M Bommer; A Forke; J Holz; P Frenz; N Wellinghausen
Journal:  Infection       Date:  2010-03-18       Impact factor: 3.553

3.  Sporadic community-acquired Legionnaires' disease in France: a 2-year national matched case-control study.

Authors:  D Che; C Campese; P Santa-Olalla; G Jacquier; D Bitar; P Bernillon; J-C Desenclos
Journal:  Epidemiol Infect       Date:  2008-01-23       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.